Bachem Peptides

Awaiting product image

Orexin A (17-33)

Orexin A (17-33) acts as selective OX1 antagonist. Truncation studies have led to OXA (17-33) as the shortest active peptide known to date with a 23-fold selectivity for OX1 over OX2. The native orexins A and B do not show distinct receptor selectivity. Both OX receptors are involved in energy homeostasis and the sleep/wake cycle, […]

SKU: 4092130

Category: All Products, Applications, Obesity Research, Peptides to Buy Online

Tags: Trifluoroacetate

Description
Additional information

Description

Orexin A (17-33) acts as selective OX1 antagonist. Truncation studies have led to OXA (17-33) as the shortest active peptide known to date with a 23-fold selectivity for OX1 over OX2. The native orexins A and B do not show distinct receptor selectivity. Both OX receptors are involved in energy homeostasis and the sleep/wake cycle, hence selective as well as dual antagonists are required for research.

Additional information

Pack size available	0.5mg, 1mg

Related products

((R)-4-Hydroxy-4-methyl-Orn(5-TAMRA)⁷)-Phalloidin

$931.00

Select options
((R)-4-Hydroxy-4-methyl-Orn(CPM-β-Mpa)⁷)-Phalloidin

$202.20

Select options
((R)-4-Hydroxy-4-methyl-Orn(TRITC)⁷)-Phalloidin

$343.74

Select options
(2-(1,3-Dithiolan-2-yl)-Trp²⁵)-Liraglutide trifluoroacetate salt

Price range: $443.00 through $2,635.40

Select options
(2-(2-Trifluoromethyl-1,3-dithiolan-2-yl)-Trp²⁵)-Liraglutide trifluoroacetate salt

Price range: $495.73 through $2,949.45

Select options

Your cart (items: 0)

Products in cart
Product	Details	Total
	Available on backorder Previous price: Discounted price:	Save